MacroGenics Net Receivables from 2010 to 2025

MGNX Stock  USD 2.77  0.21  7.05%   
MacroGenics Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables is likely to outpace its year average in 2025. During the period from 2010 to 2025, MacroGenics Net Receivables regression line of annual values had r-squared of  0.27 and arithmetic mean of  12,508,453. View All Fundamentals
 
Net Receivables  
First Reported
2012-12-31
Previous Quarter
6.2 M
Current Value
8.8 M
Quarterly Volatility
15.3 M
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.7 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 3.69. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of MacroGenics over the last few years. It is MacroGenics' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

MacroGenics Net Receivables Regression Statistics

Arithmetic Mean12,508,453
Geometric Mean7,248,507
Coefficient Of Variation113.59
Mean Deviation9,330,063
Median10,386,000
Standard Deviation14,208,844
Sample Variance201.9T
Range55M
R-Value0.52
Mean Square Error157T
R-Squared0.27
Significance0.04
Slope1,563,135
Total Sum of Squares3028.4T

MacroGenics Net Receivables History

202514.4 M
202411.9 M
202310.4 M
202256.2 M
202110.4 M
202023.1 M
201912.7 M

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables11.9 M14.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.